Skip to main content
Industry News
FDA updates drug safety signal list

The FDA analyzed data from its Adverse Event Reporting System and included 25 drugs or drug classes in its quarterly update of medications that have a potential for serious risk or have new safety information. The list, current as of Oct. 5, includes 12 drugs in the category of glucagon-like peptide 1 receptor agonists for type 2 diabetes.

Full Story: